Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Mathieu C, Dandona P, Gillard P et al (2018) Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 24-week results from a randomized controlled trial
Tell your healthcare provider if you notice a pounding, racing, or fluttering heartbeat, especially with chest discomfort, shortness of breath, or fainting
Both patients and doctors need to understand that these drugs also lower cardiovascular disease outcomes that may be even more important than their weight loss effects since cardiovascular disease is the leading cause of death for persons with diabetes or overweight/obesity (evidence already published for Ozempic showing reduction in cardiovascular events, pending for Wegovy and clinical trials are ongoing for Mounjaro). Type 2 diabetes can be managed
Newman is aboard-certified physician assistant with a doctorate in medical science, specializing in personalized virtual healthcare
Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patients
It is already stable at refrigerator temperatures for months to years
